Action ZEOX ZEO SCIENTIFIX, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Zeo ScientifiX, Inc.

Actions

ZEOX

US68621D2062

Marché Fermé - OTC Markets
Autres places de cotation
 21:28:31 16/07/2024 		Varia. 5j. Varia. 1 janv.
2,41 USD +0,42 % Graphique intraday de Zeo ScientifiX, Inc. +22,34 % +136,27 %
14/06 Zeo ScientifiX, Inc. annonce ses résultats pour le deuxième trimestre et les six mois terminés le 30 avril 2024 CI
03/06 Zeo Scientifix, Inc. annonce des changements au sein de sa direction CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Zeo ScientifiX, Inc. announced that it has received $0.5 million in funding
Zeo ScientifiX, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2024
Zeo Scientifix, Inc. Announces Management Changes
Zeo Scientifix, Inc. Announces Chief Executive Officer Changes
Zeo ScientifiX, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024
Zeo ScientifiX, Inc. has Changed its Ticker to ZEOX from OCEL
Organicell Regenerative Medicine, Inc. will Change its Name to Zeo ScientifiX, Inc
Zeo ScientifiX, Inc. Reports Earnings Results for the Full Year Ended October 31, 2023
Organicell Regenerative Medicine : Announces 1-for-200 Reverse Stock Split - Form 8-K
Organicell Regenerative Medicine, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023
Organicell Regenerative Medicine, Inc. announced a financing transaction
Organicell Regenerative Medicine : Acquisition/Asset Disposal - Form 8-K
An unknown buyer acquired Laboratory Facility Located in Basalt, Colorado from Organicell Regenerative Medicine, Inc. for $1.25 million.
Organicell Regenerative Medicine, Inc. Reports Interim Results of Phase 1/2A Research Program
Organicell Regenerative Medicine, Inc. Announces Resignation of Maria Ines Mitrani as Director
Organicell Welcomes Howard Golub as Its New EVP/CSO
Organicell Regenerative Medicine, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023
ORGANICELL REGENERATIVE MEDICINE, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
Organicell Regenerative Medicine, Inc. Announces Executive Changes
Organicell Regenerative Medicine, Inc. Announces Management Changes
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action ZEOX
  4. Actualités Zeo ScientifiX, Inc.
  5. Autres langues